Trinity biotech achieves breakthrough clinical trial results for redesigned cgm sensor

Clinical data confirms elimination of requirement for finger-stick calibration, de-risking pathway to commercialization for the company's next-generation cgm+ biosensor platform clinical data confirms elimination of requirement for finger-stick calibration, de-risking pathway to commercialization for the company's next-generation cgm+ biosensor platform
TRIB Ratings Summary
TRIB Quant Ranking